2022 Plasminogen Activation and Extracellular Proteolysis Gordon Research Conference and Seminar
2022年纤溶酶原激活和细胞外蛋白水解戈登研究会议暨研讨会
基本信息
- 批准号:10386008
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-20 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAgingAlteplaseAreaBasic ScienceBiologyBlood CirculationBlood VesselsCardiovascular DiseasesCardiovascular PhysiologyCerebrovascular DisordersClinicClinicalClinical ResearchCoagulation ProcessCollaborationsCommunicable DiseasesCommunitiesDataDevelopmentDiagnosisDiseaseEducational process of instructingEnsureEnvironmentFosteringFunctional disorderFundingGoalsGrowthHematopoiesisHolidaysHomeostasisImmunityIndividualInfectionInternationalIschemic StrokeKnowledgeLeadLocationMalignant NeoplasmsMatrix MetalloproteinasesMetabolic DiseasesMetabolismMusculoskeletal DiseasesNatural regenerationNervous System PhysiologyNeuraxisNeurodegenerative DisordersObesityOrganParticipantPathologicPathologic ProcessesPathway interactionsPeptide HydrolasesPersonsPhysiciansPhysiological ProcessesPlasminPlasminogenPlasminogen ActivatorPlayPostdoctoral FellowPreventionProcessProteinsProteolysisRecombinantsResearchResearch PersonnelRoleScientistStrokeSystemTherapeuticTissuesTranslatingTraumaTumor BiologyUnderrepresented PopulationsWomanWomen&aposs GroupWorkangiogenesiscareercerebrovascularclinically relevantexpectationexperienceextracellularfrontiergraduate studenthuman diseaseimprovedinhibitormeetingsmid-career facultynervous system disordernew technologynovel strategiespeerpeer networkspre-doctoralrecruitstem cell biologysymposiumtherapeutic target
项目摘要
Summary
Partial support is requested for graduate students and post-doctoral fellows, and junior and midcareer faculty
to participate in the Gordon Research Seminar and Conference (GRS/GRC) entitled “Plasminogen Activation
and Extracellular proteolysis”, which will be held in Ventura, CA on February 5-6 and 6-11, 2022, respectively.
This will be the 18th GRC, as the conference has been held continuously every two years since 1990. The
focus of the 2022 GRC will be on mechanisms and therapeutic targets of extracellular proteolytic enzymes,
including plasmin(ogen), plasminogen activators, coagulation proteases, matrix-metalloproteinases (MMPs),
their precursors, inhibitors, and effectors. Recent data suggest that the expression of proteases in circulation
and the extravascular compartments of tissues is tied to numerous pathological processes. Our invited
speakers and discussion leaders will present their recent and emerging work across a spectrum of basic
science and clinical topics, including cardiovascular disease, aging, cerebrovascular function, metabolic
diseases, musculoskeletal and neurodegenerative diseases, cancer, infection and immunity, tissue remodeling
and regeneration, as well as trauma. Priority will be placed on highlighting both the role these proteins play as
disease modifiers as well the utility of employing or targeting these factors for diagnosis and therapy. One of
the major goals for the 2022 GRC meeting is translating basic research into the clinic. Attendees will be
selected by invitation and from applications submitted online. They will be chosen to represent a diverse
spectrum of research, with a strong emphasis on equity of opportunity and inclusion of individuals across all
demographic metrics. Additional efforts will be committed to recruit women and scientists of underrepresented
groups as session leaders and speakers for both the GRS and GRC. Indeed, an intended strength of this
meeting will be the interaction and networking of the young scientists in the field, with the discussion leaders
and the speakers. The associated GRS, which is a younger feature of the conference, will provide a unique
opportunity for trainees and beginning scientists to present their research and share the GRC experience. This
two-day seminar will be organized by Graduate Students and Postdoctoral Fellows with the support of leading
researchers and the GRC Chairs, and will allow junior researchers within the field of plasminogen activation
and extracellular proteolysis to come together to discuss their current unpublished research, while building
informal networks with their peers that may lead to a lifetime of collaboration and scientific achievement.
概括
要求为研究生和博士后研究员提供部分支持,以及初级和中级教师
参加戈登研究研讨会和会议(GRS/GRC)的标题为“纤溶酶原激活
和细胞外蛋白水解”,将分别于2022年2月5日至6日和6-11在加利福尼亚州的文图拉举行。
这将是第18个GRC,因为自1990年以来,一次会议每两年一次举行一次。
2022 GRC的重点将放在细胞外蛋白水解酶的机制和治疗靶标上
包括纤溶酶(OGEN),纤溶酶原活化剂,凝结蛋白酶,基质 - 绝素蛋白酶(MMP),
它们的前体,抑制剂和效果。最近的数据表明蛋白酶在循环中的表达
组织的血管外室与许多病理过程有关。我们的邀请
演讲者和讨论负责人将介绍他们最近的新兴工作
科学和临床主题,包括心血管疾病,衰老,脑血管功能,代谢
疾病,肌肉骨骼和神经退行性疾病,癌症,感染和免疫学,组织重塑
和再生以及创伤。优先考虑这些蛋白质扮演的角色
疾病修饰符以及将这些因素用于诊断和治疗的实用性。之一
2022年GRC会议的主要目标是将基础研究转化为诊所。与会者会
根据邀请和在线提交的申请中选择。他们将被选为代表潜水员
研究范围,非常强调机会平等和个人包容所有人
人口指标。将努力招募妇女和代表性不足的科学家
小组作为GRS和GRC的会议负责人和演讲者。确实,这是一个预期的优势
会议将是该领域年轻科学家的互动和网络,与讨论领导者
和演讲者。相关的GRS是会议的年轻特征,将提供独特的
受训者的机会并开始科学家展示他们的研究并分享GRC的经验。这
两天的开创性将由研究生和博士后研究员组织
研究人员和GRC椅子,将允许纤溶酶原活化领域的初级研究人员
和细胞外蛋白水解聚集在一起,讨论他们当前未发表的研究,同时建立
与同行的非正式网络可能会导致一生的合作和科学成就。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHEW J FLICK其他文献
MATTHEW J FLICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHEW J FLICK', 18)}}的其他基金
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
通过靶向肿瘤微环境中的凝血来重编程 PDAC 基质
- 批准号:
10681313 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
通过靶向肿瘤微环境中的凝血来重编程 PDAC 基质
- 批准号:
10517972 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
纤溶酶原/纤维蛋白原轴与 COVID-19 发病机制的联系机制
- 批准号:
10471424 - 财政年份:2021
- 资助金额:
$ 2.3万 - 项目类别:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
纤溶酶原/纤维蛋白原轴与 COVID-19 发病机制的联系机制
- 批准号:
10676149 - 财政年份:2021
- 资助金额:
$ 2.3万 - 项目类别:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
纤溶酶原/纤维蛋白原轴与 COVID-19 发病机制的联系机制
- 批准号:
10316657 - 财政年份:2021
- 资助金额:
$ 2.3万 - 项目类别:
Fibrin(ogen) control of metabolic inflammation and obesity
纤维蛋白(原)控制代谢炎症和肥胖
- 批准号:
10311076 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Fibrin(ogen) control of metabolic inflammation and obesity
纤维蛋白(原)控制代谢炎症和肥胖
- 批准号:
10065070 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
靶向纤溶酶原激活系统以限制胰腺癌进展和相关血栓形成
- 批准号:
10458582 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Fibrin(ogen) control of metabolic inflammation and obesity
纤维蛋白(原)控制代谢炎症和肥胖
- 批准号:
10083730 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
靶向纤溶酶原激活系统以限制胰腺癌进展和相关血栓形成
- 批准号:
10022502 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10696455 - 财政年份:2023
- 资助金额:
$ 2.3万 - 项目类别:
REpeated ASseSsmEnt of SurvivorS in ICH (REASSESS ICH)
ICH 幸存者的重复评估 (REASSESS ICH)
- 批准号:
10545055 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
REpeated ASseSsmEnt of SurvivorS in ICH (REASSESS ICH)
ICH 幸存者的重复评估 (REASSESS ICH)
- 批准号:
10366955 - 财政年份:2022
- 资助金额:
$ 2.3万 - 项目类别:
Sexual Dimorphism in Cerebral Amyloid Angiopathy and Vascular Dementia: Investigating the Role of Fibrinolytic System
脑淀粉样血管病和血管性痴呆中的性别二态性:研究纤溶系统的作用
- 批准号:
10302102 - 财政年份:2021
- 资助金额:
$ 2.3万 - 项目类别: